Dr. Andrew Gary Seltzer, MD

Dr. Seltzer practices at Synovation Medical Group in Reseda, California.

Dr. Seltzer's NPI, 1811079338, was assigned on October 20, 2006. Dr. Seltzer graduated from University of California, San Diego School of Medicine in 2000. Dr. Seltzer's California license number on file is A86140.

Dr. Seltzer's primary practice is Synovation Medical Group, at 18040 W Sherman Way, Reseda, CA 91335 in Los Angeles County. The practice phone is (818) 212-2223.

Dr. Seltzer's primary practice is Synovation Medical Group in Reseda, California. The medical group on file is Synovation Medical Group. Dmand AI also links Dr. Seltzer to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seltzer practices, 2 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Seltzer's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Seltzer is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Seltzer's licenses on file in 4 states: California, Kentucky, Missouri and Wisconsin.

Dmand AI lists back pain injection, drug use disorders, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Seltzer treats.

CMS data shows 3,825 Medicare services from Dr. Seltzer across 19 procedure codes in 2024, for 725 Medicare patients. Medicare paid $283,595 for them.

CMS counts 725 Medicare patients who saw Dr. Seltzer in 2024. The largest group is 65 to 74, with 359 patients. 75% of them have arthritis, and 71% have high blood pressure. 72% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seltzer's median patient age at 62, with 60% women.

In 2024, Dr. Seltzer wrote 3,641 Medicare Part D claims for 307 patients. 89% of them were for generic drugs. CMS names the drug for 3,562 of them, across 53 drugs with 11 or more claims each, at $544,174 in total drug cost. In 2023, CMS named 3,918 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Seltzer for performance year 2024, reported individually. Dr. Seltzer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seltzer as offering telehealth.

CMS Open Payments shows 1,113 general payments to Dr. Seltzer from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Abbott Laboratories paid the most, $7,455.

Dmand AI lists 1 award for Dr. Seltzer, most recently CMS Stage 1 EHR in 2013.

Dr. Seltzer graduated from University of California, San Diego School of Medicine in 2000.

Dr. Seltzer is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.